Nothing can bring a healthcare system to its knees quite like a pandemic. What COVID-19 is leaving in its wake is a new respect for numbers - for accurate data that can predict new threats, track current ones and trigger an avalanche of innovative responses.
Nothing can bring a healthcare system to its knees quite like a pandemic. What COVID-19 is leaving in its wake is a new respect for numbers - for accurate data that can predict new threats, track current ones and trigger an avalanche of innovative responses. Armed with this heightened awareness of the value of data-driven approaches, the world is on the precipice of a new age of medicine that prioritizes evidence-based patient care.
“Why can’t healthcare be more like financial services? Or retail? Or the automotive industry? … shouldn’t healthcare, more than any other field, be data driven - using as much data in the smartest way possible to get to the best solution?” asks global business expert Harry Glorikian in the book MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market.
Glorikian, along with Malorye Allison Branca, show through examples what a new data-driven healthcare system could look like when implemented on a global basis. The authors reveal where data and cutting-edge analytics are already advancing healthcare and creating new and evolving business opportunities. Data and technology are already impacting drug development, precision medicine, and how patients with rare diseases are diagnosed and treated. Digital devices and artificial intelligence are helping doctors do their jobs faster and with greater accuracy.
The book includes interviews with dozens of healthcare leaders, and describes the business challenges and opportunities arising for those working in one of the most vibrant sectors of the world’s economy. The authors map out many of the changes taking place, and describe how they are impacting everyone from patients to researchers to insurers, and outline some predictions for the healthcare industry in the years to come. Ultimately, having the right data and knowing how to use it will be the keys to continued innovation to fill unmet needs, improve efficiency and create new ways of delivering care.
MoneyBall Medicine makes a compelling case for embracing technology and the use of data to revolutionize the healthcare system for the greater good of patients and healthcare professionals alike.
Glorikian also hosts the MoneyBall Medicine™ Podcast, a series all about the data-driven transformation of the healthcare and life sciences landscape. An influential global business expert with more than three decades of experience building successful ventures in the U.S. and around the world, Glorikian is well known for his achievements in the life sciences, healthcare, diagnostics and healthcare IT industries. He is a sought-after speaker who has addressed the National Institutes of Health, Molecular Medicine Tri-Conference, World Theranostics Congress and other audiences worldwide.
He has written numerous articles for industry publications, appeared on CBS Evening News, and has been quoted regularly by Dow Jones, The Boston Globe, BioWorld Today, Los Angeles Times, London Independent, Medical Device Daily, Science Magazine, Genetic Engineering News and many other media outlets. He is also the author of Commercializing Novel IVD’s: A Comprehensive Manual for Success.